Case-Based Debates in Onconephrology 2: Kidney Biopsy Should Be Performed in Patients with Immune Checkpoint Inhibitor-Induced AKI; Erythropoietin-Stimulating Agents Should Be Avoided in Patients with Cancer
Back to course
Video Transcription
Video Summary
Asset Caption
Nadia Al Haddad, MD, FASN; Raad Bin Zakir Chowdhury, MD, FASN; Shruti Gupta, MD, MPH; Paul Hanna, MD, MSc, FASN; Virginie Royal, MD
Keywords
immune checkpoint inhibitor
acute kidney injury
kidney biopsy
acute interstitial nephritis
metastatic melanoma
corticosteroids
infliximab
tocilizumab
ICI rechallenge